TianYu Bio-Technology Co., Ltd. (SHA:603717)

TianYu Bio-Technology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	178.05	151.6	287.73	305.66	181.46
Trading Asset Securities	-	10.29	-	-	-
Cash & Short-Term Investments	178.05	161.9	287.73	305.66	181.46
Cash Growth	9.98%	-43.73%	-5.87%	68.44%	-43.41%
Accounts Receivable	735.89	893.69	1,033	1,382	1,495
Other Receivables	167.75	307.38	294.37	296.99	229.39
Receivables	903.64	1,201	1,327	1,679	1,724
Inventory	223.77	159.63	239.74	105.95	74.45
Other Current Assets	147.34	104.87	59.85	132.42	83.03
Total Current Assets	1,453	1,627	1,914	2,223	2,063
Property, Plant & Equipment	533.56	521.79	361.86	233.26	172.62
Long-Term Investments	97.5	101.67	255.83	96.63	188.67
Goodwill	2.08	5.56	5.56	5	5
Other Intangible Assets	26.15	7.12	7.82	104.93	103.6
Long-Term Accounts Receivable	-	452.24	309.12	129.08	480.23
Long-Term Deferred Tax Assets	105.4	109.43	92.12	46.83	24.57
Long-Term Deferred Charges	4.95	5.3	4.65	3.59	18.16
Other Long-Term Assets	992.55	342.06	409.89	486.69	261.75
Total Assets	3,215	3,273	3,461	3,329	3,318
Accounts Payable	638.33	684	666.01	684.18	741.21
Accrued Expenses	27.04	19.38	16.59	6.62	7.53
Short-Term Debt	88.93	168.35	152.76	216.34	344.07
Current Portion of Long-Term Debt	190.1	77.61	39.39	311.02	63.04
Current Portion of Leases	-	25.94	33.71	6.31	79.4
Current Income Taxes Payable	1.13	-	1.35	2.28	2.15
Current Unearned Revenue	144.65	82.5	71.63	80.07	105.22
Other Current Liabilities	256.18	180.37	149.4	117.15	137.97
Total Current Liabilities	1,346	1,238	1,131	1,424	1,481
Long-Term Debt	753.37	751.37	649.16	212.11	460.95
Long-Term Leases	111.11	281.18	209.79	41	4
Long-Term Unearned Revenue	0.69	-	-	-	-
Long-Term Deferred Tax Liabilities	2.68	0.07	0.26	0.58	1.05
Other Long-Term Liabilities	292.25	167.5	36.79	39.59	10.51
Total Liabilities	2,506	2,438	2,027	1,717	1,957
Common Stock	290.15	290.15	290.15	290.15	241.8
Additional Paid-In Capital	912.21	931.77	931.9	930.16	585.65
Retained Earnings	-683.62	-576.26	-81.85	197.55	412.3
Total Common Equity	518.74	645.66	1,140	1,418	1,240
Minority Interest	189.79	188.69	293.53	193.73	120.75
Shareholders' Equity	708.53	834.35	1,434	1,612	1,360
Total Liabilities & Equity	3,215	3,273	3,461	3,329	3,318
Total Debt	1,144	1,304	1,085	786.78	951.46
Net Cash (Debt)	-965.46	-1,143	-797.09	-481.12	-770
Net Cash Per Share	-3.33	-3.94	-3.30	-1.81	-3.18
Filing Date Shares Outstanding	289.58	290.15	290.15	290.15	241.8
Total Common Shares Outstanding	289.58	290.15	290.15	290.15	241.8
Working Capital	106.45	389.31	783.56	798.86	582.38
Book Value Per Share	1.79	2.23	3.93	4.89	5.13
Tangible Book Value	490.5	632.98	1,127	1,308	1,131
Tangible Book Value Per Share	1.69	2.18	3.88	4.51	4.68
Buildings	-	98.24	7.96	176.46	162.88
Machinery	-	209.27	88.56	31.86	34.28
Construction In Progress	-	19.06	7.37	3.93	1.31
Order Backlog	-	1,378	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.